IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Peregrine Pharmaceuticals in

CUSIP: 713661304 | 182 institutional holders

Quarters

Q4 2017Q3 2017Q2 2017Q1 2017Q4 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2017

Freedom Investment Management, Inc.148,176
0.0% of portfolio›$575
Baxter Bros Inc12,215
0.0% of portfolio›$47
StyleTurnoverLocationFiled
Freedom Investment Management, Inc.
148,176$5750.0%ETFLowSouth Windsor, CT2018-01-25
Baxter Bros Inc
12,215$470.0%CoreLowRiverside, CT2018-02-01